ISHARES TR - ISHARES BIOTECH (IBB)

CUSIP: 464287556

Q2 2022 13F Holders as of 30 Jun 2022

Share change
-1,188,905
Put/Call ratio
123%
SEC-reported price per share
$117.63
Number of holders
847
Value change
-$150,124,982
Number of buys
285
Open additional details 1 more signal available
Number of sells
425

Security key

464287556

Report period

Q2 2022

Institutions

847

Top holders

10

Ownership snapshot

Top reported holders of IBB - ISHARES TR - ISHARES BIOTECH (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Disclosed value leader
Comparable rows
0/0
Latest evidence
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

13F holder rows

Institutional holders as of Q2 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
847
Shares
39,837,799
Rows available
847
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders
880
Q2 2022 holders
847
Holder diff
-33
Investor Q1 2022 Shares Q2 2022 Shares Share Diff Share Chg % Q1 2022 value Q2 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .